Publications by authors named "P Matyus"

Claim this Profile
T
The MAO-B Inhibitor Selegiline Reduces the Viability of Different Prostate Cancer Cell Lines and Enhances the Effects of Anti-Androgen and Cytostatic Agents.
Anita Steib, Krisztina Pohóczky, Norbert Tóth, Viktória Kormos, József Kun

Pharmacol Res Perspect· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Novel multitarget analgesic candidate SZV-1287 demonstrates potential disease-modifying effects in the monoiodoacetate-induced osteoarthritis mouse model.
Ádám István Horváth, Kata Bölcskei, Nikolett Szentes, Éva Borbély, Valéria Tékus

Front Pharmacol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective Effect of Selegiline (R-deprenyl) in Aminoglycoside-Induced Hearing Loss.
Viktória Humli, Judit Szepesy, Gabriella Zsilla, Ildikó Miklya, Júlia Timár

Neurochem Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of SZV-2649, a new multiple ion channel inhibitor mexiletine analogue.
Aiman Saleh A Mohammed, Muhammad Naveed, Tamara Szabados, István Szatmári, Bálint Lőrinczi

Sci Rep· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel multitarget analgesic candidate SZV-1287 demonstrates potential disease-modifying effects in the monoiodoacetate-induced osteoarthritis mouse model.
Ádám István Horváth, Kata Bölcskei, Nikolett Szentes, Éva Borbély, Valéria Tékus

Front Pharmacol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis